✦ LIBER ✦

Modeling of Internal Dose Distributions during SR-89 Treatment of a Patient with Bone Metastases

✍ Scribed by Bialkowski, Miroslaw M.; Wierzbicki, Jacek G.; Porter, Arthur T.

Book ID: 125522995
Publisher: Mary Ann Liebert
Year: 1997
Tongue: English
Weight: 862 KB
Volume: 12
Category: Article
ISSN: 1084-9785
DOI: 10.1089/cbr.1997.12.355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strontium-89 (Sr-89) chloride in the tre

Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases

✍ Zenda, Sadamoto; Nakagami, Yoshihiro; Toshima, Masamichi; Arahira, Satoko; Kawas 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 196 KB

Strontium-89 (Sr-89) chloride in the tre

Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases

✍ Zenda, Sadamoto; Nakagami, Yoshihiro; Toshima, Masamichi; Arahira, Satoko; Kawas 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 196 KB

Intravenous pamidronate disodium treatme

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

✍ Donna Glover; Alan Lipton; Alan Keller; Antonius A. Miller; Scott Browning; Robe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

A Phase I/II study of strontium-89 combi

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

✍ Lance C. Pagliaro; Ebrahim S. Delpassand; Dallas Williams; Randall E. Millikan; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium‐89 to patients with androgen independent prostate carcinoma. ## METHODS Patients with androgen‐independent pr